{"entity":{"type":"insider","cik":"0001931825","url":"/insider/0001931825","json_url":"/insider/0001931825.json","name":"Column Group Opportunity III, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":62,"n_filings":28,"first":"2022-10-27","last":"2026-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Column Group Opportunity III, LP","source":"filing","n_filings":28,"first_seen":"2022-10-27","last_seen":"2026-02-26"}],"transactions":[{"id":6036469,"accession":"0001193125-26-076814","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-076814","line_url":"/filing/0001193125-26-076814#line-4","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1862545.0,"shares_display":"1,862,545","price_per_share":0.5624,"price_display":"0.56","price_state":"stated","total_value":1047495.308,"total_display":"1,047,495.31","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":6036466,"accession":"0001193125-26-076814","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-076814","line_url":"/filing/0001193125-26-076814#line-3","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1649281.0,"shares_display":"1,649,281","price_per_share":0.5624,"price_display":"0.56","price_state":"stated","total_value":927555.6344,"total_display":"927,555.63","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-26","scope":"insider"},{"id":6036463,"accession":"0001193125-26-076814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-076814","line_url":"/filing/0001193125-26-076814#line-2","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":349212.0,"shares_display":"349,212","price_per_share":0.6153,"price_display":"0.62","price_state":"stated","total_value":214870.1436,"total_display":"214,870.14","shares_owned_after":1862545.0,"shares_owned_after_display":"1,862,545","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":6036460,"accession":"0001193125-26-076814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-076814","line_url":"/filing/0001193125-26-076814#line-1","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":309228.0,"shares_display":"309,228","price_per_share":0.6153,"price_display":"0.62","price_state":"stated","total_value":190267.9884,"total_display":"190,267.99","shares_owned_after":1649281.0,"shares_owned_after_display":"1,649,281","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":6171220,"accession":"0001193125-26-067007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-067007","line_url":"/filing/0001193125-26-067007#line-4","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162291.0,"shares_display":"162,291","price_per_share":0.5972,"price_display":"0.60","price_state":"stated","total_value":96920.1852,"total_display":"96,920.19","shares_owned_after":2211757.0,"shares_owned_after_display":"2,211,757","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider"},{"id":6171216,"accession":"0001193125-26-067007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-067007","line_url":"/filing/0001193125-26-067007#line-3","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143709.0,"shares_display":"143,709","price_per_share":0.5972,"price_display":"0.60","price_state":"stated","total_value":85823.0148,"total_display":"85,823.01","shares_owned_after":1958509.0,"shares_owned_after_display":"1,958,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider"},{"id":6171211,"accession":"0001193125-26-067007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-067007","line_url":"/filing/0001193125-26-067007#line-2","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":277769.0,"shares_display":"277,769","price_per_share":0.6149,"price_display":"0.61","price_state":"stated","total_value":170800.1581,"total_display":"170,800.16","shares_owned_after":2374048.0,"shares_owned_after_display":"2,374,048","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-24","scope":"insider"},{"id":6171202,"accession":"0001193125-26-067007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-067007","line_url":"/filing/0001193125-26-067007#line-1","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":245965.0,"shares_display":"245,965","price_per_share":0.6149,"price_display":"0.61","price_state":"stated","total_value":151243.8785,"total_display":"151,243.88","shares_owned_after":2102218.0,"shares_owned_after_display":"2,102,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-24","scope":"insider"},{"id":5762216,"accession":"0001193125-26-049028","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-049028","line_url":"/filing/0001193125-26-049028#line-4","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2151458.0,"shares_display":"2,151,458","price_per_share":0.6808,"price_display":"0.68","price_state":"stated","total_value":1464712.6064,"total_display":"1,464,712.61","shares_owned_after":2651817.0,"shares_owned_after_display":"2,651,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":5762215,"accession":"0001193125-26-049028","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-049028","line_url":"/filing/0001193125-26-049028#line-3","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1905115.0,"shares_display":"1,905,115","price_per_share":0.6808,"price_display":"0.68","price_state":"stated","total_value":1297002.292,"total_display":"1,297,002.29","shares_owned_after":2348183.0,"shares_owned_after_display":"2,348,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":5762214,"accession":"0001193125-26-049028","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-049028","line_url":"/filing/0001193125-26-049028#line-2","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182295.0,"shares_display":"182,295","price_per_share":0.8161,"price_display":"0.82","price_state":"stated","total_value":148770.9495,"total_display":"148,770.95","shares_owned_after":4803275.0,"shares_owned_after_display":"4,803,275","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-12","scope":"insider"},{"id":5762213,"accession":"0001193125-26-049028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-049028","line_url":"/filing/0001193125-26-049028#line-1","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161422.0,"shares_display":"161,422","price_per_share":0.8161,"price_display":"0.82","price_state":"stated","total_value":131736.4942,"total_display":"131,736.49","shares_owned_after":4253298.0,"shares_owned_after_display":"4,253,298","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-12","scope":"insider"},{"id":5958428,"accession":"0001193125-26-043320","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320#line-10","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1437323.0,"shares_display":"1,437,323","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":25871814.0,"total_display":"25,871,814.00","shares_owned_after":4312139.0,"shares_owned_after_display":"4,312,139","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":5958425,"accession":"0001193125-26-043320","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320#line-9","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":630881.0,"shares_display":"630,881","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":11355858.0,"total_display":"11,355,858.00","shares_owned_after":1319164.0,"shares_owned_after_display":"1,319,164","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":5958422,"accession":"0001193125-26-043320","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193125-26-043320","line_url":"/filing/0001193125-26-043320#line-8","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Eikon Therapeutics, Inc.","issuer_ticker":"EIKN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Kutzkey Tim; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49556.0,"shares_display":"49,556","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":892008.0,"total_display":"892,008.00","shares_owned_after":148840.0,"shares_owned_after_display":"148,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":6194331,"accession":"0001193125-26-016991","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991#line-6","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9568.0,"shares_display":"9,568","price_per_share":19.5999,"price_display":"19.60","price_state":"stated","total_value":187531.8432,"total_display":"187,531.84","shares_owned_after":1016658.0,"shares_owned_after_display":"1,016,658","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider"},{"id":6194315,"accession":"0001193125-26-016991","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991#line-5","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8484.0,"shares_display":"8,484","price_per_share":19.5999,"price_display":"19.60","price_state":"stated","total_value":166285.5516,"total_display":"166,285.55","shares_owned_after":900292.0,"shares_owned_after_display":"900,292","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider"},{"id":6194311,"accession":"0001193125-26-016991","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991#line-4","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1358.0,"shares_display":"1,358","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":27160.0,"total_display":"27,160.00","shares_owned_after":1007090.0,"shares_owned_after_display":"1,007,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":6194308,"accession":"0001193125-26-016991","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991#line-3","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1204.0,"shares_display":"1,204","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":24080.0,"total_display":"24,080.00","shares_owned_after":891808.0,"shares_owned_after_display":"891,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":6194306,"accession":"0001193125-26-016991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991#line-2","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6303.0,"shares_display":"6,303","price_per_share":19.889,"price_display":"19.89","price_state":"stated","total_value":125360.367,"total_display":"125,360.37","shares_owned_after":1005732.0,"shares_owned_after_display":"1,005,732","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider"},{"id":6194304,"accession":"0001193125-26-016991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-016991","line_url":"/filing/0001193125-26-016991#line-1","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5590.0,"shares_display":"5,590","price_per_share":19.889,"price_display":"19.89","price_state":"stated","total_value":111179.51,"total_display":"111,179.51","shares_owned_after":890604.0,"shares_owned_after_display":"890,604","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider"},{"id":6015971,"accession":"0001193125-26-014100","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-014100","line_url":"/filing/0001193125-26-014100#line-4","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2927.0,"shares_display":"2,927","price_per_share":19.9883,"price_display":"19.99","price_state":"stated","total_value":58505.7541,"total_display":"58,505.75","shares_owned_after":999429.0,"shares_owned_after_display":"999,429","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-14","filed_date":"2026-01-15","scope":"insider"},{"id":6015968,"accession":"0001193125-26-014100","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-014100","line_url":"/filing/0001193125-26-014100#line-3","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2596.0,"shares_display":"2,596","price_per_share":19.9883,"price_display":"19.99","price_state":"stated","total_value":51889.6268,"total_display":"51,889.63","shares_owned_after":885014.0,"shares_owned_after_display":"885,014","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-14","filed_date":"2026-01-15","scope":"insider"},{"id":6015964,"accession":"0001193125-26-014100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-014100","line_url":"/filing/0001193125-26-014100#line-2","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6609.0,"shares_display":"6,609","price_per_share":19.8041,"price_display":"19.80","price_state":"stated","total_value":130885.2969,"total_display":"130,885.30","shares_owned_after":996502.0,"shares_owned_after_display":"996,502","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":6015958,"accession":"0001193125-26-014100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-014100","line_url":"/filing/0001193125-26-014100#line-1","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5861.0,"shares_display":"5,861","price_per_share":19.8041,"price_display":"19.80","price_state":"stated","total_value":116071.8301,"total_display":"116,071.83","shares_owned_after":882418.0,"shares_owned_after_display":"882,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":6194235,"accession":"0001193125-26-007857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-007857","line_url":"/filing/0001193125-26-007857#line-2","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8003.0,"shares_display":"8,003","price_per_share":19.8872,"price_display":"19.89","price_state":"stated","total_value":159157.2616,"total_display":"159,157.26","shares_owned_after":989893.0,"shares_owned_after_display":"989,893","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":6194226,"accession":"0001193125-26-007857","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-007857","line_url":"/filing/0001193125-26-007857#line-1","is_derivative":false,"issuer_cik":"0001606074","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001606074","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; Svennilson Peter; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7097.0,"shares_display":"7,097","price_per_share":19.8872,"price_display":"19.89","price_state":"stated","total_value":141139.4584,"total_display":"141,139.46","shares_owned_after":876557.0,"shares_owned_after_display":"876,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":4093590,"accession":"0001193125-25-311384","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-311384","line_url":"/filing/0001193125-25-311384#line-4","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16381.0,"shares_display":"16,381","price_per_share":19.5409,"price_display":"19.54","price_state":"stated","total_value":320099.4829,"total_display":"320,099.48","shares_owned_after":981890.0,"shares_owned_after_display":"981,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-08","scope":"insider"},{"id":4093587,"accession":"0001193125-25-311384","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-25-311384","line_url":"/filing/0001193125-25-311384#line-3","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14503.0,"shares_display":"14,503","price_per_share":19.5409,"price_display":"19.54","price_state":"stated","total_value":283401.6727,"total_display":"283,401.67","shares_owned_after":869460.0,"shares_owned_after_display":"869,460","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-08","scope":"insider"},{"id":4093581,"accession":"0001193125-25-311384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-311384","line_url":"/filing/0001193125-25-311384#line-2","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2791.0,"shares_display":"2,791","price_per_share":17.347,"price_display":"17.35","price_state":"stated","total_value":48415.477,"total_display":"48,415.48","shares_owned_after":965509.0,"shares_owned_after_display":"965,509","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-08","scope":"insider"},{"id":4093577,"accession":"0001193125-25-311384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-311384","line_url":"/filing/0001193125-25-311384#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2475.0,"shares_display":"2,475","price_per_share":17.347,"price_display":"17.35","price_state":"stated","total_value":42933.825,"total_display":"42,933.82","shares_owned_after":854957.0,"shares_owned_after_display":"854,957","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-08","scope":"insider"},{"id":4796054,"accession":"0001193125-25-284943","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-284943","line_url":"/filing/0001193125-25-284943#line-2","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":167307.0,"shares_display":"167,307","price_per_share":12.65,"price_display":"12.65","price_state":"stated","total_value":2116433.55,"total_display":"2,116,433.55","shares_owned_after":962718.0,"shares_owned_after_display":"962,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":4796050,"accession":"0001193125-25-284943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-284943","line_url":"/filing/0001193125-25-284943#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":148150.0,"shares_display":"148,150","price_per_share":12.65,"price_display":"12.65","price_state":"stated","total_value":1874097.5,"total_display":"1,874,097.50","shares_owned_after":852482.0,"shares_owned_after_display":"852,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":4235371,"accession":"0000950170-25-047104","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-047104","line_url":"/filing/0000950170-25-047104#line-3","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":365769.0,"shares_display":"365,769","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":4242920.4,"total_display":"4,242,920.40","shares_owned_after":795411.0,"shares_owned_after_display":"795,411","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-28","scope":"insider"},{"id":4235367,"accession":"0000950170-25-047104","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-047104","line_url":"/filing/0000950170-25-047104#line-2","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":344827.0,"shares_display":"344,827","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":3999993.2,"total_display":"3,999,993.20","shares_owned_after":344827.0,"shares_owned_after_display":"344,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-28","scope":"insider"},{"id":4235363,"accession":"0000950170-25-047104","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-047104","line_url":"/filing/0000950170-25-047104#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":323886.0,"shares_display":"323,886","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":3757077.6,"total_display":"3,757,077.60","shares_owned_after":704332.0,"shares_owned_after_display":"704,332","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-26","filed_date":"2025-03-28","scope":"insider"},{"id":4099898,"accession":"0000950170-25-035789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-035789","line_url":"/filing/0000950170-25-035789#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35714284.0,"shares_display":"35,714,284","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":24999998.8,"total_display":"24,999,998.80","shares_owned_after":49313559.0,"shares_owned_after_display":"49,313,559","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":2234984,"accession":"0000950170-24-015234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-015234","line_url":"/filing/0000950170-24-015234#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG Opportunity III GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2222222.0,"shares_display":"2,222,222","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":9999999.0,"total_display":"9,999,999.00","shares_owned_after":13599275.0,"shares_owned_after_display":"13,599,275","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":8530681,"accession":"0000950170-23-064854","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064854","line_url":"/filing/0000950170-23-064854#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5840.0,"shares_display":"5,840","price_per_share":0.6211,"price_display":"0.62","price_state":"stated","total_value":3627.224,"total_display":"3,627.22","shares_owned_after":949862.0,"shares_owned_after_display":"949,862","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":8530677,"accession":"0000950170-23-064854","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064854","line_url":"/filing/0000950170-23-064854#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP GP, LP; COLUMN GROUP III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP L P; Column Group IV GP, LP; Column Group IV, LP; Column Group IV-A, LP; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; TCG IV GP, LLC","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16791.0,"shares_display":"16,791","price_per_share":0.7075,"price_display":"0.71","price_state":"stated","total_value":11879.6325,"total_display":"11,879.63","shares_owned_after":944022.0,"shares_owned_after_display":"944,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-15","filed_date":"2023-11-17","scope":"insider"},{"id":8032682,"accession":"0000899243-23-008390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-008390","line_url":"/filing/0000899243-23-008390#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"Column Group Opportunity III GP, LP; COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III-A, LP; Column Group Opportunity III, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6779.0,"shares_display":"6,779","price_per_share":2.5956,"price_display":"2.60","price_state":"stated","total_value":17595.5724,"total_display":"17,595.57","shares_owned_after":11377053.0,"shares_owned_after_display":"11,377,053","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-10","filed_date":"2023-03-14","scope":"insider"},{"id":8669129,"accession":"0000899243-23-004584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-004584","line_url":"/filing/0000899243-23-004584#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III GP, LP; COLUMN GROUP III, LP; Column Group Opportunity III GP, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III-A, LP; Column Group Opportunity III, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":3900000.0,"total_display":"3,900,000.00","shares_owned_after":11370274.0,"shares_owned_after_display":"11,370,274","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-10","scope":"insider"},{"id":7987197,"accession":"0000899243-23-003137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-003137","line_url":"/filing/0000899243-23-003137#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":176730.0,"shares_display":"176,730","price_per_share":4.9986,"price_display":"5.00","price_state":"stated","total_value":883402.578,"total_display":"883,402.58","shares_owned_after":927231.0,"shares_owned_after_display":"927,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-01","scope":"insider"},{"id":7987193,"accession":"0000899243-23-003137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-003137","line_url":"/filing/0000899243-23-003137#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group IV GP, LP; COLUMN GROUP L P; COLUMN GROUP III-A, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; Column Group IV, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7542.0,"shares_display":"7,542","price_per_share":4.9996,"price_display":"5.00","price_state":"stated","total_value":37706.9832,"total_display":"37,706.98","shares_owned_after":750501.0,"shares_owned_after_display":"750,501","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-30","filed_date":"2023-02-01","scope":"insider"},{"id":8350602,"accession":"0000899243-23-002637","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002637","line_url":"/filing/0000899243-23-002637#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"COLUMN GROUP L P; Column Group IV GP, LP; Column Group Opportunity III, LP; COLUMN GROUP III, LP; Column Group IV-A, LP; Column Group IV, LP; Column Group Opportunity III GP, LP; COLUMN GROUP GP, LP; TCG IV GP, LLC; COLUMN GROUP III-A, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9900.0,"shares_display":"9,900","price_per_share":4.9994,"price_display":"5.00","price_state":"stated","total_value":49494.06,"total_display":"49,494.06","shares_owned_after":742959.0,"shares_owned_after_display":"742,959","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-25","scope":"insider"},{"id":8350589,"accession":"0000899243-23-002380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002380","line_url":"/filing/0000899243-23-002380#line-2","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.996,"price_display":"5.00","price_state":"stated","total_value":2498.0,"total_display":"2,498.00","shares_owned_after":733059.0,"shares_owned_after_display":"733,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-20","filed_date":"2023-01-23","scope":"insider"},{"id":8720429,"accession":"0000899243-23-002382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002382","line_url":"/filing/0000899243-23-002382#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"COLUMN GROUP III, LP; TCG Opportunity III GP, LLC; Column Group Opportunity III GP, LP; Column Group Opportunity III, LP; COLUMN GROUP III-A, LP; COLUMN GROUP III GP, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69739.0,"shares_display":"69,739","price_per_share":2.4979,"price_display":"2.50","price_state":"stated","total_value":174201.0481,"total_display":"174,201.05","shares_owned_after":9870274.0,"shares_owned_after_display":"9,870,274","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-23","scope":"insider"},{"id":8350582,"accession":"0000899243-23-002380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002380","line_url":"/filing/0000899243-23-002380#line-1","is_derivative":false,"issuer_cik":"0001347769","issuer_name":"NGM BIOPHARMACEUTICALS INC","issuer_ticker":"NGM","issuer_name_source":null,"issuer_url":"/issuer/0001347769","owner_cik":null,"owner_name":"Column Group IV GP, LP; TCG IV GP, LLC; COLUMN GROUP GP, LP; Column Group IV, LP; Column Group Opportunity III, LP; COLUMN GROUP L P; COLUMN GROUP III, LP; Column Group IV-A, LP; COLUMN GROUP III-A, LP; Column Group Opportunity III GP, LP","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":37639.0,"shares_display":"37,639","price_per_share":4.9976,"price_display":"5.00","price_state":"stated","total_value":188104.6664,"total_display":"188,104.67","shares_owned_after":732559.0,"shares_owned_after_display":"732,559","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-23","scope":"insider"},{"id":8421246,"accession":"0000899243-23-002161","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002161","line_url":"/filing/0000899243-23-002161#line-2","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group Opportunity III GP, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III, LP; COLUMN GROUP III GP, LP; COLUMN GROUP III-A, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":135688.0,"shares_display":"135,688","price_per_share":2.5163,"price_display":"2.52","price_state":"stated","total_value":341431.7144,"total_display":"341,431.71","shares_owned_after":9800535.0,"shares_owned_after_display":"9,800,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-19","scope":"insider"},{"id":8421240,"accession":"0000899243-23-002161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-002161","line_url":"/filing/0000899243-23-002161#line-1","is_derivative":false,"issuer_cik":"0001668085","issuer_name":"Tenaya Therapeutics, Inc.","issuer_ticker":"TNYA","issuer_name_source":null,"issuer_url":"/issuer/0001668085","owner_cik":null,"owner_name":"Column Group Opportunity III, LP; Column Group Opportunity III GP, LP; TCG Opportunity III GP, LLC; COLUMN GROUP III, LP; COLUMN GROUP III GP, LP; COLUMN GROUP III-A, LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49463.0,"shares_display":"49,463","price_per_share":2.4947,"price_display":"2.49","price_state":"stated","total_value":123395.3461,"total_display":"123,395.35","shares_owned_after":9664847.0,"shares_owned_after_display":"9,664,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"}],"next_cursor":"2023-01-17|8421240","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001858848","name":"Tenaya Therapeutics, Inc.","url":"/issuer/0001858848","role":"Ten percent owner","n_filings":10,"first_seen":"2022-11-23","last_seen":"2026-02-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001861123","name":"Eikon Therapeutics, Inc.","url":"/issuer/0001861123","role":"Ten percent owner","n_filings":1,"first_seen":"2026-02-09","last_seen":"2026-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001824893","name":"Surrozen, Inc./DE","url":"/issuer/0001824893","role":"Ten percent owner","n_filings":6,"first_seen":"2025-03-28","last_seen":"2026-01-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001426332","name":"NGM BIOPHARMACEUTICALS INC","url":"/issuer/0001426332","role":"Ten percent owner","n_filings":11,"first_seen":"2022-10-27","last_seen":"2023-11-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001931825","retrieved_at":"2026-08-21T04:31:45+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}